Literature DB >> 17298617

Trends in colorectal cancer survival following the 2-week rule.

S R Walsh1, N L Gilson, K Brown, J R Novell.   

Abstract

OBJECTIVE: The 2-week rule has reduced waiting times for a specialist opinion among patients with a suspected malignancy. We aimed at assessing the effect of this rule on colorectal cancer survival.
METHOD: Patients diagnosed with colorectal cancer before (group 1) and after (group 2) the introduction of the 2-week rule were identified from a prospective database. Emergency patients were excluded. Overall 2-year survival for each group was calculated using the Kaplan-Meier method and compared using the log-rank test.
RESULTS: Waiting times fell from 26 to 21 days (P =0.22). There was no significant difference in 2-year survival between the groups (hazard ratio 1.1; P = 0.56). There was a slight divergence between the survival curves at 2 years.
CONCLUSION: There has been no improvement in 2-year survival from colorectal cancer following the introduction of the 2-week rule.

Entities:  

Mesh:

Year:  2007        PMID: 17298617     DOI: 10.1111/j.1463-1318.2006.01105.x

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  4 in total

1.  Audit of two-week rule referrals for suspected testicular cancer in Cornwall, 2003-2005.

Authors:  Prakash Kumaraswamy; Robert Cox; John S O'Rourke; Robert G Willis
Journal:  Ann R Coll Surg Engl       Date:  2009-02-13       Impact factor: 1.891

2.  Interhospital referral of colorectal cancer patients: a Dutch population-based study.

Authors:  A K Warps; M P M de Neree Tot Babberich; E Dekker; M W J M Wouters; J W T Dekker; R A E M Tollenaar; P J Tanis
Journal:  Int J Colorectal Dis       Date:  2021-03-20       Impact factor: 2.571

3.  Has the 'Fast-Track' referral system affected the route of presentation and/or clinical outcomes in patients with colorectal cancer?

Authors:  Luke Thornton; Harriet Reader; Stevan Stojkovic; Victoria Allgar; Nick Woodcock
Journal:  World J Surg Oncol       Date:  2016-06-08       Impact factor: 2.754

4.  Wait times from diagnosis to treatment in cancer.

Authors:  Laurie Elit
Journal:  J Gynecol Oncol       Date:  2015-09-23       Impact factor: 4.401

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.